Prospective study of impact of numbers of cardiotoxic chemotherapy and frequency on arrhythmia occurrence in patients with breast cancer

14 April 2026 (08:00 - 14:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Sung Il Im

kosin university gospel hospital, Pusan (Korea (Republic of))

188 More presentations in this session

Presentation thumbnail

Comparison of ECG findings between young patients with cryptogenic ischemic stroke and stroke-free control subjects

Doctor J. Uutela (Jyvaskyla, FI)

Presentation thumbnail

A wearable SCG-based approach for early, low-cost screening of valvular heart disease

Doctor V. Pergola (Naples, IT)

Presentation thumbnail

Intraoperative assessment of cardiac parasympathetic tone using short-term HRV metrics before and after atropine administration: a pilot study

Doctor B. Hrymniak (Wroclaw, PL)

Presentation thumbnail

Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance

Doctor Y. Shhab (Bucharest, RO)

Presentation thumbnail

Arrhythmias and device therapy in HFpEF: Insights from a real-world hospital cohort

Ms A. Bondoc (Timisoara, RO)

Abstract Slides Video

Access the full session

Session thumbnail

Poster session (3): mechanisms and management of arrhythmias

The Event

Event poster

EHRA 2026

14 April 2026 08:00 CET

You may be interested in

Congress Presentation

Prospective study of impact of cardiotoxic chemotherapy protocol and frequency on arrhythmia occurrence in patients with breast cancer

Congress Presentation

New onset of left ventricular dysfunction and diastolic dysfunction are uncommon in patients with her2+ breast cancer after completion of cancer therapy.

Congress Presentation

Decoding chemotherapy-related cardiac dysfunction prediction: left ventricular strain imaging or HFA-ICOS score?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources